Serotonin-5-O-carboxymethyl-glycyl[125I]tyrosinamide labels the 5-HT1Dβ receptor subtype in human cortex
- 28 September 1993
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 242 (2), 195-198
- https://doi.org/10.1016/0014-2999(93)90080-2
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- A subfamily of 5-HT1D receptor genesTrends in Pharmacological Sciences, 1992
- An investigation of the 5-HT1D receptor binding affinity of 5-hydroxytryptamine, 5-carboxyamidotryptamine and sumatriptan in the central nervous system of seven speciesEuropean Journal of Pharmacology, 1992
- Homogeneous 5-HT1D recognition sites in the human substantia nigra identified with a new iodinated radioligandEuropean Journal of Pharmacology, 1991
- Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brainTrends in Pharmacological Sciences, 1989
- The genomic clone G-21 which resembles a β-adrenergic receptor sequence encodes the 5-HT1A receptorNature, 1988
- Molecular Characterization of a Functional cDNA Encoding the Serotonin 1c ReceptorScience, 1988
- Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranesJournal of Neuroscience, 1987
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973